Tuesday, July 14, the Alzheimer's Talks Teleconference from 4-5 p.m. ET will feature Dr. Michael Rafii, director of the Memory Disorders Clinic and assistant professor of Neurosciences at the University of California, San Diego. He will discuss the NOBLE trial, a clinical study to evaluate an investigational drug for patients with mild-to-moderate Alzheimer's disease, and what it means for research.
He will discuss … a clinical study to evaluate an investigational drug for patients with mild-to-moderate Alzheimer's disease.
Dr. Rafii is also Medical Director of the National Institutes of Health-funded Alzheimer's Disease Cooperative Study and Attending Neurologist at the Shiley-Marcos Alzheimer's Disease Research Center.
Alzheimer’s Talks is a monthly teleconference series produced by USAgainstAlzheimer's to raise awareness about issues, and unite advocates with researchers or policy leaders. These informational interactive calls run much like a radio talk show, and provide caregivers, researchers, non-profit leaders, government officials, and other advocates direct access to the nation’s leading researchers in Alzheimer’s disease.
Anyone can join the free call via phone or online, or afterwards through the podcast or transcript. You can register for the call at Alzheimer’s Talks.
The Wednesday, Aug. 19, Alzheimer's Talks Teleconference will feature Dr. Scott Mackin, associate professor of Psychiatry at University of California, San Francisco School of Medicine who is principal investigator for the Alzheimer's Disease Neuroimaging Initiative Depression Project.